New triple drug therapy for newly diagnosed type 2 diabetes
Treatments studied
Part of Hormones & metabolism clinical trials.
This study tests a new combination of three diabetes medicines for people recently diagnosed with type 2 diabetes. It aims to see if this triple therapy controls blood sugar better than the standard two-drug approach.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have been diagnosed with type 2 diabetes within the last year.
- You have not taken diabetes medication for at least 3 months before starting, or have taken it for less than 3 months in total.
- Your latest HbA1c (average blood sugar over 3 months) is between 6.5% and 9.0%.
- Your BMI is 24 or higher.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new combination of three medicines to improve blood sugar control in people who are newly diagnosed with type 2 diabetes. It may help reduce blood sugar levels and support weight loss.
This trial tests if newer diabetes medications can reduce heart risk and help achieve diabetes remission in people newly diagnosed with type 2 diabetes. It may be an option if you have not taken diabetes drugs before or stopped them over three months ago, and your blood sugar and weight are in certain ranges.
This early-stage study tests a new experimental drug (NNC0487-0111) designed to help regulate insulin levels in adults with type 2 diabetes. Researchers want to see if it works safely and effectively when combined with your current diabetes medications.
This study tests a combination of three diabetes medicines (empagliflozin, linagliptin, and metformin) to see if it helps control blood sugar in people with type 2 diabetes. It may be an option if your current treatment isn't working well enough.
This trial tests a combination of three diabetes medicines to see if they can quickly get high blood sugar under control in people newly diagnosed with type 2 diabetes. It's designed for those whose HbA1c is 9.0% or higher.
This trial tests a combination of three diabetes medicines (henagliflozin proline, retagliptin, and metformin) for people newly diagnosed with type 2 diabetes. The goal is to see how well the combination controls blood sugar and to check its safety.
Hear when a new Diabetes Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.